Vistagen Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2025 | — | $70.4M | $67.1M |
| FY2026 | — | $35.5M | $30.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2025 | — | $70.4M | $67.1M |
| FY2026 | — | $35.5M | $30.8M |